Table 2.

Magnitude and significance of differences in sST2 concentration between patients with preeclampsia and those with normal pregnancies according to gestational age. The magnitude of differences is expressed as percentage changes [(preeclampsia-control)/control * 100] and significance p-values was obtained from linear mixed-effects models.

GA	sST2 (pg/mL)		Percentage difference	p-value
	Preeclampsia	Control
10	7294.5	7368.0	−1.0	0.91
11	7192.7	7436.7	−3.3	0.67
12	7098.0	7466.2	−4.9	0.48
13	7013.9	7462.6	−6.0	0.37
14	6943.6	7432.7	−6.6	0.32
15	6890.4	7383.4	−6.7	0.31
16	6857.5	7321.7	−6.3	0.33
17	6848.0	7254.4	−5.6	0.40
18	6865.6	7188.0	−4.5	0.50
19	6914.0	7129.0	−3.0	0.65
20	6997.5	7083.5	−1.2	0.86
21	7121.1	7057.6	0.9	0.89
22	7290.6	7057.5	3.3	0.62
23	7513.3	7089.4	6.0	0.37
24	7797.6	7160.3	8.9	0.19
25	8154.4	7277.8	12.0	0.079
26	8596.9	7450.8	15.4	0.028
27	9142.0	7690.2	18.9	0.0087
28	9811.1	8009.2	22.5	0.0024
29	10631.5	8424.5	26.2	0.0006
30	11638.5	8957.7	29.9	0.0001
31	12878.3	9636.8	33.6	<0.0001
32	14411.2	10498.9	37.3	<0.0001
33	16317.3	11593.7	40.7	<0.0001
34	18703.8	12988.2	44.0	<0.0001
35	21715.6	14774.8	47.0	<0.0001
36	25550.7	17081.5	49.6	<0.0001
37	30482.1	20088.8	51.7	<0.0001
38	36891.6	24054.3	53.4	<0.0001
39	45318.7	29351.6	54.4	<0.0001
40	56535.2	36531.0	54.8	<0.0001
41	71660.5	46416.4	54.4	0.0001